| abstract |
The present invention relates to a novel glucose-6-phosphate translocase inhibitor L 970885, which is produced by an Actinomycete sp. (culture number HIL-000337) during fermentation, a process for its preparation, to chemical derivatives derived from compound L 970885, to the use of compound L 970885 and derivatives derived therefrom and pharmacological active substances, as medicament and, in particular, for the treatment of diabetes mellitus, and to an Actinomycete sp. HIL-000337 (DSM 11992) for producing the abovementioned compound L 970885. |